about
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationImaging tumor hypoxia to advance radiation oncologyPatents in genomics and human geneticsErythropoietin blockade inhibits the induction of tumor angiogenesis and progression.Thromboembolic and bleeding complications in acute leukemia.Protective effects of erythropoietin and N-acetylcysteine on methotrexate-induced lung injury in rats.Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitromiR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.The effect of erythropoietin on normal and neoplastic cells.Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.Erythropoietin and cancer: the unintended consequences of anemia correctionErythropoietin after a century of research: younger than ever.Are cancer stem cells radioresistant?Methylation impact analysis of erythropoietin (EPO) Gene to hypoxia inducible factor-1α (HIF-1α) activityEpigenetic silencing of erythropoietin in human cancersUnderstanding tumor heterogeneity as functional compartments--superorganisms revisited.Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinibRisks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.Role of subchondral bone during early-stage experimental TMJ osteoarthritis.Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusionErythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrityExpression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathyJAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?Impact of increased erythropoietin receptor expression and elevated serum erythropoietin levels on clinicopathological features and prognosis in renal cell carcinoma.Neurorestorative treatment of stroke: cell and pharmacological approaches.Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.Advances in hemorrhagic stroke therapy: conventional and novel approaches.Role of erythropoietin in cancer-related anaemia: a double-edged sword?Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma.Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients.
P2860
Q24306910-0E661765-7869-410B-A426-639044B98AC5Q27007862-A921248B-C232-4198-BBC0-F67D3C89AF5CQ28749392-18A6175E-22EC-4366-B395-188C2FE007F3Q33288270-6AAD000A-7240-4C4B-B38F-4331ED9C759BQ33392897-56BD2F55-BB3C-43D3-AF8D-DB86DCB80EC5Q33974376-AB3FF26F-9726-4074-9BA8-72DB00702B75Q34107767-654E1E26-7354-48E2-A2F3-1E1015C1A222Q34248579-5194EE6F-5C66-42BA-AADE-3B59CC7C34B9Q34291437-8ECF750E-1157-4E07-90FD-4A5AC396CBEBQ34326017-48047CF5-7663-4FED-85C3-20D782970B0BQ34428148-13351DE9-2D9F-401F-BC5F-A2D349B35D6FQ34488415-F05A26BB-76E4-4D50-920C-184AB3BBDA90Q34606348-2EC4FF2B-DEC2-4F24-942D-5DF2F0F0C885Q34686233-B712EB57-5639-4A63-8DC3-921B70E51AC6Q34983448-0009C8D2-1109-41F7-BFE5-6888BBF42177Q35034068-F3EE0E6F-B151-42F7-BA4B-EDA5CF6E10DBQ35054645-5411F2EB-899A-4D8B-8820-2066BDB256E7Q35073857-74D50064-5DAD-4E1E-8615-50432666CFA8Q35164312-4C65955E-395A-48FF-ACE7-5CAE9FE6BF22Q35225120-78C284AF-CCD0-4337-99DC-CB40976FD112Q35283018-89D71A48-1A44-437E-8C12-233B62706994Q35570450-641B4954-AEAB-4E2E-94EA-18566A0E1D14Q35633372-827CC384-D313-4A57-A65F-B6221264C8E5Q35741127-370AC2AA-DA00-4CB4-AC5B-821716F151EDQ35950357-EE122497-80C2-44E4-BCE2-D82905B6C9E6Q36025893-F122AB20-8062-4B33-BED8-1E753AEE2BAFQ36178175-67AE30B1-A3F5-4657-9AD6-400AD58587A7Q36224287-450C5E23-F802-40AC-9739-AE05879B3751Q36608810-BD044DA2-B559-47E9-B279-ABAA64B348A7Q36610386-6E6B3254-04B3-4918-9D15-F5BD5D28A2EDQ36645651-DFEB159C-27EE-4DA4-B6C5-528E43D170C8Q36819627-D8700DAA-83E5-455D-B110-75451B303511Q36840259-77587C9E-F515-43D5-BF8A-425F43BE8B72Q36944012-7113E52B-E2E6-45D7-9822-6CF2D498E980Q37071262-D91F0C55-7975-4023-951C-8F411E8719D0Q37151778-DD4F705A-35D8-4D36-A012-BDF5BF19CD53Q37164573-FC1DDD27-1E96-41B6-BB1C-2EDB9DB797DFQ37253676-89E15210-B91C-415C-AE48-F61DAADBF12AQ37350312-A373EEA7-FBE9-4E83-B6B4-DEF22C2C0842Q37390664-A91A0E88-BE0D-4997-B8F4-B5C664A8F3F4
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Erythropoietin biology in cancer.
@ast
Erythropoietin biology in cancer.
@en
type
label
Erythropoietin biology in cancer.
@ast
Erythropoietin biology in cancer.
@en
prefLabel
Erythropoietin biology in cancer.
@ast
Erythropoietin biology in cancer.
@en
P2093
P1476
Erythropoietin biology in cancer
@en
P2093
Kimberly L Blackwell
Mark W Dewhirst
Matthew E Hardee
Murat O Arcasoy
P304
P356
10.1158/1078-0432.CCR-05-1771
P407
P577
2006-01-01T00:00:00Z